The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AKILI INC | COMMON STOCK | 00974B107 | 18,996,800 | 11,873,000 | SH | SOLE | 11,873,000 | 0 | 0 | |||
| PROKIDNEY CORP | CLASS A ORD SHS | G7S53R104 | 150,250,360 | 13,273,000 | SH | SOLE | 13,273,000 | 0 | 0 | |||
| SOCIAL CAP SUVRETTA HLDS CRP | CLASS A ORD SHS | G8253U103 | 6,540,800 | 640,000 | SH | OTR | 0 | 640,000 | 0 | |||
| SOCIAL CAP SUVRETTA HLDS CP | CLASS A ORD SHS | G8253Y105 | 6,540,800 | 640,000 | SH | OTR | 0 | 640,000 | 0 | |||